top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
Neuralink Raises $650M as Clinical Trials Commence for Brain Implant Technology
Fremont, CA, June 2, 2025 (Reuters) -- Elon Musk’s Neuralink has raised $650 million to support the advancement of its brain implant...
NanoVibronix Names Doron Besser as CEO, Succeeding Brian Murphy
New York, NY, June 4, 2025 (Nasdaq) -- NanoVibronix, Inc. has named Doron Besser as its new Chief Executive Officer, effective...
Eli Lilly Acquires SiteOne Therapeutics in $1B Deal to Bolster Non-Opioid Pain
Indianapolis, IN, May 27, 2025 (PRNewswire) -- Eli Lilly and Company announced it will acquire SiteOne Therapeutics, a biotech firm...
PharmaLogic Names Etienne Montagut as President and CEO, Signaling New Growth Chapter in Radiopharmaceutical CDMO Sector
Boca Raton, FL, June 2, 2025 (PRNewswire) -- PharmaLogic Holdings Corp. has appointed Etienne Montagut, formerly of Lantheus, GE...
Sanofi Acquires Blueprint Medicines in $9.1B Deal, Bolstering Rare Immunology Pipeline
Paris and Cambridge, MA, June 2, 2025Â (GlobeNewswire) -- Sanofi will acquire Blueprint Medicines for approximately $9.1 billion, adding...
Alpheus Medical Raises $52M to Advance Non-Invasive Glioblastoma Therapy into Phase 2B Trial
Chanhassen, MN, May 15, 2025 (PRNewswire) -- Alpheus Medical secured $52 million in Series B funding to advance a Phase 2B clinical...
David Llewellyn Takes Helm as CEO at Trailhead Biosystems
Beachwood, OH, May 20, 2025 (PRNewswire) -- Trailhead Biosystems has appointed David Llewellyn, PhD, MBA, as its new CEO, marking a...
Paratek Closes $330M Optinose Purchase
Boston, MA, May 21, 2025 (Globe Newswire) -- Paratek Pharmaceuticals has acquired Optinose in a $330 million transaction, expanding its...
Medtech Veteran Mark Grant Named CEO of Lifeward
Marlborough, MA, May 19, 2025 (Globe Newswire) -- Lifeward has named Mark Grant as its new CEO, bringing in a seasoned commercial...
Pfizer Strikes $6B+ Oncology Deal with 3SBio for Global Rights to Promising Bispecific Antibody SSGJ-707
New York, May 19, 2025 (Business Wire) -- Pfizer has entered into a global (ex-China) licensing agreement with 3SBio for SSGJ-707, a...
NewLimit Raises $130M to Advance Gene Reprogramming for Human Longevity, Reaches $810M Valuation
San Francisco, CA, May 6, 2025 (NewLimit) -- NewLimit, a biotech startup co-founded by Coinbase CEO Brian Armstrong, has raised $130...
Biohaven Lands Strategic $600M Deal with Oberland Capital to Fuel Troriluzole Launch and Pipeline Growth
New Haven, CT, April 28, 2025 (PRNewswire) -- Biohaven Ltd. has secured up to $600 million in non-dilutive financing from Oberland...
AEON Biopharma Appoints Industry Veteran Rob Bancroft as CEO
Irvine, CA, April 23, 2025 (Globe Newswire) -- AEON Biopharma has named Rob Bancroft as its new CEO as it accelerates development of...
Merck Accelerates U.S. Expansion and Rare Tumor Strategy with $3.9B Acquisition of SpringWorks Therapeutics
Stamford, CT, April 28, 2025 (Merck) -- Merck is acquiring SpringWorks Therapeutics for $3.9 billion in a deal that strengthens its...
RadNet to acquire iCAD for $103M to advance AI-powered breast cancer detection worldwide
Los Angeles, CA and Nashua, NH, April 15, 2025 (Globe Newswire) -- RadNet will acquire iCAD for approximately $103 million in an...
Galapagos appoints Henry Gosebruch as Founding CEO of SpinCo amid strategic corporate separation
Mechelen, Belgium, and Boston MA, April 21, 2025 (Globe Newswire) -- Galapagos NV appointed Henry Gosebruch as founding CEO of its...
Glycomine raises $115M to advance first-in-class PMM2-CDG therapy GLM101 into Phase 2b trial
San Carlos, CA, April 16, 2025 (Glycomine) -- Glycomine has secured $115 million in Series C financing to fund a Phase 2b trial of...
Calidi Biotherapeutics appoints Eric Poma as CEO to lead next phase of cancer virotherapy development
San Diego, CA, April 23, 2025 (Globe Newswire) -- Eric Poma, Ph.D., has been appointed CEO of Calidi Biotherapeutics, succeeding Allan...
Repertoire partners with Genentech in $765M deal to develop T cell-targeted autoimmune therapies
Cambridge, MA, April 22, 2025 (PRNewswire) -- Repertoire Immune Medicines has entered into a strategic partnership with Genentech to...
AIRNA Raises $155M to Advance RNA Editing Therapy for Genetic Lung and Liver Disease
Cambridge, MA and Tubingen, Germany, April 6, 2025 (Business Wire) -- AIRNA secured $155 million in an oversubscribed Series B to...
bottom of page